How to treat the nonalcoholic fatty liver disease?

被引：0
作者：
Cadranel, Jean-Francois [1 ]
机构：
[1] Ctr Hosp Laennec, Serv Hepatogastroenterol & Nutr, Creil, France
来源：
CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION | 2009年 / 13卷 / 06期
关键词：
Nonalcoholic steatohepatitis; NASH; Weight loss; Bariatric surgery; Glitazones; Metformine; Vitamin E; PLACEBO-CONTROLLED TRIAL; STEATOHEPATITIS; ROSIGLITAZONE; PIOGLITAZONE; IMPROVEMENT;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：234 / 238
页数：5
相关论文
共 17 条
  • [1] Abdelmalek MF, 2001, AM J GASTROENTEROL, V96, P2711
  • [2] Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
    Aithal, Guruprasad P.
    Thomas, James A.
    Kaye, Philip V.
    Lawson, Adam
    Ryder, Stephen D.
    Spendlove, Ian
    Austin, Andrew S.
    Freeman, Jan G.
    Morgan, Linda
    Weeber, Jonathan
    [J]. GASTROENTEROLOGY, 2008, 135 (04) : 1176 - 1184
  • [3] Nonalcoholic fatty liver disease
    Brunt, Elizabeth M.
    Wong, Vincent W. -S.
    Nobili, Valerio
    Day, Christopher P.
    Sookoian, Silvia
    Maher, Jacquelyn J.
    Bugianesi, Elisabetta
    Sirlin, Claude B.
    Neuschwander-Tetri, BrentA.
    Rinella, Mary E.
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2015, 1
  • [4] A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
    Belfort, Renata
    Harrison, Stephen A.
    Brown, Kenneth
    Darland, Celia
    Finch, Joan
    Hardies, Jean
    Balas, Bogdan
    Gastaldelli, Amalia
    Tio, Fermin
    Pulcini, Joseph
    Berria, Rachele
    Ma, Jennie Z.
    Dwivedi, Sunil
    Havranek, Russell
    Fincke, Chris
    DeFronzo, Ralph
    Bannayan, George A.
    Schenker, Steven
    Cusi, Kenneth
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (22) : 2297 - 2307
  • [5] Nonalcoholic fatty liver disease
    Clark, JM
    Brancati, FL
    Diehl, AM
    [J]. GASTROENTEROLOGY, 2002, 122 (06) : 1649 - 1657
  • [6] Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study
    de Ledinghen, Victor
    Ratziu, Vlad
    Causse, Xavier
    Le Bail, Brigitte
    Capron, Dominique
    Renou, Christophe
    Pilette, Christophe
    Oules, Valerie
    Gelsi, Eve
    Oberti, Frederic
    Vallet-Pichard, Anais
    Le Provost, Nicolas
    Cadranel, Jean-Francois
    [J]. JOURNAL OF HEPATOLOGY, 2006, 45 (04) : 592 - 599
  • [7] Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
    Dixon, JB
    Bhathal, PS
    Hughes, NR
    O'Brien, PE
    [J]. HEPATOLOGY, 2004, 39 (06) : 1647 - 1654
  • [8] Harrison SA, 2003, AM J GASTROENTEROL, V98, P926, DOI 10.1111/j.1572-0241.2003.07375.x
  • [9] Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial
    Lindor, KD
    Kowdley, KV
    Heathcote, EJ
    Harrison, ME
    Jorgensen, R
    Angulo, P
    Lymp, JF
    Burgart, L
    Colin, P
    [J]. HEPATOLOGY, 2004, 39 (03) : 770 - 778
  • [10] Metformin in non-alcoholic steatohepatitis
    Marchesini, G
    Brizi, M
    Bianchi, G
    Tomassetti, S
    Zoli, M
    Melchionda, N
    [J]. LANCET, 2001, 358 (9285) : 893 - 894
12